![Xiao Qin Lu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xiao Qin Lu
Directeur/Membre du Conseil chez
VERU INC.
Fortune : 2 323 $ au 31/05/2026
Profil
Xiao Qin Lu currently works at Veru, Inc., as Independent Director from 2021, Inventia Healthcare Ltd., as Director from 2018, Innovative Cellular Therapeutics Co., Ltd., as Chief Operating Officer, Innovative Cellular Therapeutics, Inc., as Chief Operating Officer, and Fortress Biotech, Inc., as Chief Strategy Officer from 2025.
Dr. Lu also formerly worked at Checkpoint Therapeutics, Inc., as Chief Executive Officer from 2014 to 2015, Avenue Therapeutics, Inc., as President, CEO, CFO & Director in 2022, Veru, Inc., as Independent Director from 2016 to 2019, Inventiva SA, as Independent Director from 2018 to 2025, Fortress Biotech, Inc., as Director from 2022 to 2025, Citigroup Global Markets, Inc. (Broker), as Research Analyst, Fortress Biotech, Inc., as CFO, Executive VP & Head-Investor Relations from 2013 to 2017, Broadpoint.Gleacher Securities, as Vice President, Lehman Brothers Global Asset Management, as Analyst from 2001 to 2004, and Lazard Asset Management LLC, as Analyst from 2001 to 2004.
Dr. Lu received her Masters Business Admin degree from The Leonard N Stern School of Business, doctorate degree from New York University School of Medicine, and undergraduate degree from College of Arts & Sciences (TN).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VERU INC 0,01% | 04/05/2026 | 980 ( 0,01% ) | 2 323 $ | 31/05/2026 |
Postes actifs de Xiao Qin Lu
| Sociétés | Poste | Début |
|---|---|---|
| VERU INC. | Directeur/Membre du Conseil | 14/05/2021 |
| FORTRESS BIOTECH, INC. | Corporate Officer/Principal | 21/04/2025 |
Innovative Cellular Therapeutics, Inc.
 Innovative Cellular Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cellular immunotherapies for the treatment of solid tumors | Directeur des opérations | 01/04/2022 |
Innovative Cellular Therapeutics Co., Ltd.
 Innovative Cellular Therapeutics Co., Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops cellular immunotherapies for the treatment of solid tumors | Directeur des opérations | - |
Inventia Healthcare Ltd.
 Inventia Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/01/2018 |
Anciens postes connus de Xiao Qin Lu
| Sociétés | Poste | Fin |
|---|---|---|
| INVENTIVA | Directeur/Membre du Conseil | 21/05/2025 |
| FORTRESS BIOTECH, INC. | Directeur/Membre du Conseil | 15/04/2025 |
| AVENUE THERAPEUTICS, INC. | Directeur Général | 31/03/2022 |
| VERU INC. | Directeur/Membre du Conseil | 26/03/2019 |
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Xiao Qin Lu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Veru, Inc.
 Veru, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, markets and sells female condoms and develops drugs for cancer treatment | Health Technology |
Citigroup Global Markets, Inc. (Broker)
 Citigroup Global Markets, Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
Broadpoint.Gleacher Securities
 Broadpoint.Gleacher Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
Lehman Brothers Global Asset Management
 Lehman Brothers Global Asset Management Investment Banks/BrokersFinance Asset management | Finance |
Lazard Asset Management LLC
 Lazard Asset Management LLC Investment ManagersFinance LAM offers products across a broad spectrum of asset classes, designed for different client types. The firm’s traditional and alternative investment services cover listed equity and fixed income investments in a wide range of global, regional and country specific strategies. Risk management is integral to their portfolio construction. They rely heavily on fundamental, bottom-up investment research. | Finance |
Inventia Healthcare Ltd.
Inventia Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
College of Arts & Sciences (TN)
 College of Arts & Sciences (TN) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkpoint Therapeutics, Inc.
 Checkpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Avenue Therapeutics, Inc.
 Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
Innovative Cellular Therapeutics Co., Ltd.
Innovative Cellular Therapeutics Co., Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops cellular immunotherapies for the treatment of solid tumors | Health Technology |
Innovative Cellular Therapeutics, Inc.
Innovative Cellular Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cellular immunotherapies for the treatment of solid tumors | Health Technology |
